Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

Gastroenterology

Volumn 126, Issue 6, 2004, Pages 1504-1517

  Loftus Jr , Edward V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

AGE; APPENDECTOMY; ASIA; ATYPICAL MYCOBACTERIOSIS; CHILDHOOD DISEASE; CIGARETTE SMOKING; CROHN DISEASE; DEMOGRAPHY; DEVELOPING COUNTRY; DIET; ENTERITIS; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ETHNIC DIFFERENCE; EUROPE; GEOGRAPHY; HUMAN; MEASLES; NORTH AMERICA; ORAL CONTRACEPTION; PERINATAL INFECTION; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; TIME; ULCERATIVE COLITIS; UNITED STATES; VACCINATION;

EID: 2442563304     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2004.01.063     Document Type: Article

References (178)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med 2002;347:417-429.
2. Orholm M, Binder V, Sorensen TIA, Rasmussen LP, Kyvik KO. Concordance of inflammatory bowel disease among Danish twins-results of a nationwide study. Scand J Gastroenterol 2000;35:1075-1081.
3. Halfvarson J, Bodin L, Tysk C, Lindberg E, Jamerot G. Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. Gastroenterology 2003;124:1767-1773.
4. Loftus EV Jr, Sandborn WJ. Epidemiology of inflammatory bowel disease. Gastroenterol Clin North Am 2002;31:1-20.
5. Daiss W, Scheurlen M, Malchow H. Epidemiology of inflammatory bowel disease in the county of Tubingen (West Germany). Scand J Gastroenterol Suppl 1989;170:39-43.
6. Roin F, Roin J. Inflammatory bowel disease of the Faroe Islands, 1981-1988. A prospective epidemiologic study: primary report. Scand J Gastroenterol Suppl 1989;170:44-46.
7. Halme L, von Smitten K, Husa A. The incidence of Crohn's disease in the Helsinki metropolitan area during 1975-1985. Ann Chir Gynaecol 1989;78:115-119.
8. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol 1991;26:1247-1256.
9. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol 1992;27:609-614.
10. Gower-Rousseau C, Salomez JL, Dupas JL, Marti R, Nuttens MC, Votte A, Lemahieu M, Lemaire B, Colombel JF, Cortot A. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-1438.
11. Stewenius J, Adnerhill I, Ekelund G, Floren CH, Fork FT, Janzon L, Lindstrom C, Mars I, Nyman M, Rosengren JE. Ulcerative colitis and indeterminate colitis in the city of Malmo, Sweden. A 25-year incidence study. Scand J Gastroenterol 1995;30:38-43.
12. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Stray N, Sauar J, Schulz T. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. Scand J Gastroenterol 1996;31:355-361.
13. Moum B, Vatn MH, Ekbom A, Aadland E, Fausa O, Lygren I, Sauar J, Schulz T, Stray N. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. Scand J Gastroenterol 1996;31:362-326.
14. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blankenstein M. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-697.
15. Lapidus A, Bernell O, Hellers G, Persson PG, Lofberg R. Incidence of Crohn's disease in Stockholm County 1955-1989. Gut 1997;41:480-486.
16. Russel MG, Dorant E, Volovics A, Brummer RJ, Pop P, Muris JW, Bos LP, Limonard CB, Stockbrugger RW. High incidence of inflammatory bowel disease in The Netherlands: results of a prospective study. Dis Colon Rectum 1998;41:33-40.
17. Bjornsson S, Johannsson JH, Oddsson E. Inflammatory bowel disease in Iceland, 1980-89. A retrospective nationwide epidemiologic study. Scand J Gastroenterol 1998;33:71-77.
18. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000;12:31-33.
19. Kyle J. Crohn's disease in the northeastern and northern Isles of Scotland: an epidemiological review. Gastroenterology 1992;103:392-399.
20. Montgomery SM, Morris DL, Thompson NP, Subhani J, Pounder RE, Wakefield AJ. Prevalence of inflammatory bowel disease in British 26 year olds: national longitudinal birth cohort. BMJ 1998;316:1058-1059.
21. Yapp TR, Stenson R, Thomas GAO, Lawrie BW, Williams GT, Hawthorne AB. Crohn's disease incidence in Cardiff from 1930: an update for 1991-1995. Eur J Gastroenterol Hepatol 2000;12:907-911.
22. Rubin GP, Hungin APS, Kelly PJ, Ling J. Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 2000;14:1553-1559.
23. Pinchbeck BR, Kirdeikis J, Thomson AB. Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol 1988;10:505-515.
24. Hiatt RA, Kaufman L. Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med 1988;149:541-546.
25. Stowe SP, Redmond SR, Stormont JM, Shah AN, Chessin LN, Segal HL, Chey WY. An epidemiologic study of inflammatory bowel disease in Rochester, New York. Hospital Incidence. Gastroenterology 1990;98:104-110.
26. Kurata JH, Kantor-Fish S, Frankl H, Godby P, Vadheim CM. Crohn's disease among ethnic groups in a large health maintenance organization. Gastroenterology 1992;102:1940-8194.
27. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival [published erratum appears in Gastroenterology 1999;116:1507]. Gastroenterology 1998;114:1161-1168.
28. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival [published erratum appears in Gastroenterology 1999;116:1507]. Gastroenterology 1998;114:1161-1168.
29. Bernstein CN, Blanchard JF, Rawsthorne P, Wajda A. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol 1999;149:916-924.
30. Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut 2000;46:336-343.
31. Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001;154:328-335.
32. Loftus CG, Loftus EV, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Update on incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota. (abstr) Gastroenterology 2003;124:A36.
33. Vucelic B, Korac B, Sentic M, Milicic D, Hadzic N, Juresa V, Bozikov J, Rotkvic I, Buljevac M, Kovacevïc I. Epidemiology of Crohn's disease in Zagreb, Yugoslavia: a ten-year prospective study. Intl J Epidemiol 1991;20:216-220.
34. Vucelic B, Korac B, Sentic M, Milicic D, Hadzic N, Juresa V, Bozikov J, Rotkvic I, Buljevac M, Kovacevic I. Ulcerative colitis in Zagreb, Yugoslavia: incidence and prevalence 1980-1989. Intl J Epidemiol 1991;20:1043-1047.
35. Mate-Jimenez J, Munoz S, Vicent D, Pajares JM. Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988. J Clin Gastroenterol 1994;18:27-31.
36. Manousos ON, Koutroubakis I, Potamianos S, Roussomoustakaki M, Gourtsoyiannis N, Vlachonikolis IG. A prospective epidemiologic study of Crohn's disease in Heraklion, Crete. Incidence over a 5-year period. Scand J Gastroenterol 1996;31:599-603.
37. Manousos ON, Giannadaki E, Mouzas IA, Tzardi M, Koutroubakis I, Skordilis P, Vassilakis S, Kouroumalis E, Vlachonikolis IG. Ulcerative colitis is as common in Crete as in northern Europe: a 5-year prospective study. Eur J Gastroenterol Hepatol 1996;8:893-898.
38. Trallori G, Palli D, Saieva C, Bardazzi G, Bonanomi AG, d'Albasio G, Galli M, Vannozzi G, Milla M, Tarantino O, Renai F, Messod A, Amorosi A, Pacini F, Morettini A. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). Scand J Gastroenterol 1996;31:892-899.
39. Tragnone A, Corrao G, Miglio F, Caprilli R, Lanfranchi GA. Incidence of inflammatory bowel disease in Italy: a nationwide population-based study. Intl J Epidemiol 1996;25:1044-1052.
40. Odes HS, Fraser D, Krawiec J. Incidence of idiopathic ulcerative colitis in Jewish population subgroups in the Beer Sheva region of Israel. Am J Gastroenterol 1987;82:854-858.
41. Fireman Z, Grossman A, Lilos P, Eshchar Y, Theodor E, Gilat T. Epidemiology of Crohn's disease in the Jewish population of central Israel, 1970-1980. Am J Gastroenterol 1989;84:255-258.
42. Grossman A, Fireman Z, Lilos P, Novis B, Rozen P, Gilat T. Epidemiology of ulcerative colitis in the Jewish population of central Israel 1970-1980. Hepatogastroenterology 1989;36:193-197.
43. Odes HS, Locker C, Neumann L, Zirkin HJ, Weizman Z, Sperber AD, Fraser GM, Krugliak P, Gaspar N, Eidelman L. Epidemiology of Crohn's disease in southern Israel. Am J Gastroenterol 1994;89:1859-1862.
44. Morita N, Toki S, Hirohashi T, Minoda T, Ogawa K, Kono S, Tamakoshi A, Ohno Y, Sawada T, Muto T. Incidence and prevalence of inflammatory bowel disease in Japan: nationwide epidemiological survey during the year 1991. J Gastroenterol 1995;30:1-4.
45. Yang SK, Hong WS, Min YI, Kim HY, Yoo JY, Rhee PL, Rhee JC, Chang DK, Song IS, Jung SA, Park EB, Yoo HM, Lee DK, Kim YK. Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol 2000;15:1037-1042.
46. Lee YM, Fock KM, See SJ, Ng TM, Khor C, Teo EK. Racial differences in the prevalence of ulcerative colitis and Crohn's disease in Singapore. J Gastroenterol Hepatol 2000;15:622-625.
47. Sood A, Midha V, Sood N, Bhatia AS, Avasthi G. Incidence and prevalence of ulcerative colitis in Punjab, North India. Gut 2003;52:1587-1590.
48. Wright JP, Froggatt J, O'Keefe EA, Ackerman S, Watermeyer S, Louw J, Adams G, Girdwood AH, Bums DG, Marks IN. The epidemiology of inflammatory bowel disease in Cape Town 1980-1984. S Afr Med J 1986;70:10-15.
49. Linares de la Cal JA, Canton C, Hermida C, Perez-Miranda M, Mate-Jimenez J. Estimated incidence of inflammatory bowel disease in Argentina and Panama (1987-1993). Rev Esp Enferm Dig 1999;91:277-286.
50. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991;100:143-149.
51. Sonnenberg A, Wasserman IH. Epidemiology of inflammatory bowel disease among U.S. military veterans. Gastroenterology 1991;101:122-130.
52. Ogunbi SO, Ransom JA, Sullivan K, Schoen BT, Gold BD. Inflammatory bowel disease in African-American children living in Georgia. J Pediatr 1998;133:103-107.
53. Loftus EV Jr, Schoenfeld P, Sandborn WJ. The epidemiology and natural history of Crohn's disease in population-based patient cohorts from North America: a systematic review. Aliment Pharmacol Ther 2002;16:51-60.
54. Sawczenko A, Sandhu BK, Logan RFA, Jenkins H, Taylor CJ, Mian S, Lynn R. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-1094.
55. Fellows IW, Freeman JG, Holmes GK. Crohn's disease in the city of Derby, 1951-85. Gut 1990;31:1262-1265.
56. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut 1992;33:687-693.
57. Carr I, Mayberry JF. The effects of migration on ulcerative colitis: a three-year prospective study among Europeans and first- and second-generation South Asians in Leicester (1991-1994). Am J Gastroenterol 1999;94:2918-2922.
58. Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999;11:543-546.
59. Harries AD, Baird A, Rhodes J. Non-smoking: a feature of ulcerative colitis. BMJ 1982;284:706.
60. Jick H, Walker AM. Cigarette smoking and ulcerative colitis. N Engl J Med 1983;308:261-263.
61. Logan RF, Edmond M, Somerville KW, Langman MJ. Smoking and ulcerative colitis. BMJ 1984;288:751-753.
62. Gyde SN, Prior P, Alexander F, Evans S, Taylor K, John WG, Waterhouse JA, Allan RN. Ulcerative colitis: why is the mortality from cardiovascular disease reduced? Q J Med 1984;53:351-357.
63. Thornton JR, Emmett PM, Heaton KW. Smoking, sugar, and inflammatory bowel disease. BMJ 1985;290:1786-1787.
64. Vessey M, Jewell D, Smith A, Yeates D, McPherson K. Chronic inflammatory bowel disease, cigarette smoking, and use of oral contraceptives: findings in a large cohort study of women of childbearing age. BMJ 1986;292:1101-1103.
65. Tobin MV, Logan RF, Langman MJ, McConnell RB, Gilmore IT. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987;93:316-321.
66. Benoni C, Nilsson A. Smoking habits in patients with inflammatory bowel disease. A case-control study. Scand J Gastroenterol 1987;22:1130-1136.
67. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987;316:707-710.
68. Franceschi S, Panza E, La Vecchia C, Parazzini F, Decarli A, Blanchi Porro G. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 1987;125:445-452.
69. Lindberg E, Tysk C, Andersson K, Jarnerot G. Smoking and inflammatory bowel disease. A case control study. Gut 1988;29:352-357.
70. Lorusso D, Leo S, Misciagna G, Guerra V. Cigarette smoking and ulcerative colitis. A case control study. Hepatogastroenterology 1989;36:202-204.
71. Persson PG, Ahlbom A, Hellers G. Inflammatory bowel disease and tobacco smoke-a case-control study. Gut 1990;31:1377-1381.
72. Sandler RS, Sandler DP, McDonnell CW, Wurzelmann JI. Childhood exposure to environmental tobacco smoke and the risk of ulcerative colitis. Am J Epidemiol 1992;135:603-608.
73. Nakamura Y, Labarthe DR. A case-control study of ulcerative colitis with relation to smoking habits and alcohol consumption in Japan. Am J Epidemiol 1994;140:902-911.
74. Silverstein MD, Lashner BA, Hanauer SB. Cigarette smoking and ulcerative colitis: a case-control study. Mayo Clin Proc 1994;69:425-429.
75. Reif S, Lavy A, Keter D, Fich A, Eliakim R, Halak A, Broide E, Niv Y, Ron Y, Patz J, Odes S, Villa Y, Gilat T. Lack of association between smoking and Crohn's disease but the usual association with ulcerative colitis in Jewish patients in Israel: a multicenter study. Am J Gastroenterol 2000;95:474-478.
76. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989;34:1841-1854.
77. Rubin DT, Hanauer SB. Smoking and inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000;12:855-862.
78. Agarwal A, Rhodes JM. Smoking and IBD. IBD Monitor 2003;4:114-119.
79. Loftus EV, Sandborn WJ, Tremaine WJ, Mahoney DW, Zinsmeister AR, Offord KP, Melton U. Primary sclerosing cholangitis is associated with nonsmoking-a case-control study. Gastroenterology 1996;110:1496-1502.
80. van Erpecum KJ, Smits SJ, van de Meeberg PC, Linn FH, Wolfhagen FH, vanBerge-Henegouwen GP, Algra A. Risk of primary sclerosing cholangitis is associated with nonsmoking behavior. Gastroenterology 1996;110:1503-1506.
81. Mitchell SA, Thyssen M, Orchard TR, Jewell DP, Fleming KA, Chapman RW. Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study. Gut 2002;51:567-573.
82. Merrett MN, Mortensen N, Kettlewell M, Jewell DO. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996;38:362-364.
83. Boyko EJ, Perera DR, Koepsell TD, Keane EM, Inui TS. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988;23:1147-1152.
84. Rudra T, Motley R, Rhodes J. Does smoking improve colitis? Scand J Gastroenterol Suppl 989;170:61-63.
85. Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001;96:2113-2116.
86. Pullan RD, Rhodes J, Ganesh S, Mani V, Morris JS, Williams GT, Newcombe RG, Russell MA, Feyerabend C, Thomas GA. Transdermal nicotine for active ulcerative colitis. N Engl J Med 1994;330:811-815.
87. Sandborn WJ, Tremaine WJ, Offord KP, Lawson GM, Petersen BT, Batts KP, Croghan IT, Dale LC, Schroeder DR, Hurt RD. Transdermal nicotine for mildly to moderately active ulcerative colitis-a randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997;126:364-371.
88. Thomas GA, Rhodes J, Mani V, Williams GT, Newcombe RG, Russell MA, Feyerabend C. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995;332:988-992.
89. Thomas GA, Rhodes J, Ragunath K, Mani V, Williams GT, Newcombe RG, Russell MA, Feyerabend C. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Eur J Gastroenterol Hepatol 1996;8:769-776.
90. Harries AD, Jones L, Heatley RV, Rhodes J. Smoking habits and inflammatory bowel disease: effect on nutrition. BMJ 1982;284:1161.
91. Somerville KW, Logan RF, Edmond M, Langman MJ. Smoking and Crohn's disease. BMJ 1984;289:954-956.
92. Silverstein MD, Lashner BA, Hanauer SB, Evans AA, Kirsner JB. Cigarette smoking in Crohn's disease. Am J Gastroenterol 1989;84:31-33.
93. Reif S, Klein I, Arber N, Gilat T. Lack of association between smoking and inflammatory bowel disease in Jewish patients in Israel. Gastroenterology 1995;108:1683-1687.
94. Fich A, Eliakim R, Sperber AD, Carel RS, Rachmilewitz D. The association between smoking and inflammatory bowel disease among israeli jewish patients. Inflamm Bowel Dis 1997;3:6-9.
95. Lindberg E, Jarnerot G, Huitfeldt B. Smoking in Crohn's disease: effect on localisation and clinical course. Gut 1992;33:779-782.
96. Russel MG, Volovics A, Schoon EJ, van Wijlick EH, Logan RF, Shivananda S, Stockbrugger RW. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? Inflamm Bowel Dis 1998;4:182-186.
97. Picco MF, Bayless TM. Tobacco consumption and disease duration are associated with fistulizing and stricturing behaviors in the first 8 years of Crohn's disease. Am J Gastroenterol 2003;98:363-368.
98. Sutherland LR, Ramcharan S, Bryant H, Fick G. Effect of cigarette smoking on recurrence of Crohn's disease. Gastroenterology 1990;98:1123-1128.
99. Breuer-Katschinski BD, Hollander N, Goebell H. Effect of cigarette smoking on the course of Crohn's disease. Eur J Gastroenterol Hepatol 1996;8:225-228.
100. Timmer A, Sutherland LR, Martin F. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease. Gastroenterology 1998;114:1143-1150.
101. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999;13:1403-1411.
102. Russel MG, Nieman FH, Bergers JM, Stockbrugger RW. Cigarette smoking and quality of life in patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 1996;8:1075-1081.
103. Cosnes J, Beaugerie L, Carbonnel F, Gendre JP. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001;120:1093-1099.
104. Lashner BA, Shaheen NJ, Hanauer SB, Kirschner BS. Passive smoking is associated with an increased risk of developing inflammatory bowel disease in children. Am J Gastroenterol 1993;88:356-359.
105. Eliakim R, Reif S, Lavy A, Keter D, Odes S, Halak A, Broide E, Niv Y, Ron Y, Paz J, Fich A, Villa Y, Gilat T. Passive smoking in patients with inflammatory bowel disease: an Israeli multicentre case-control study. Eur J Gastroenterol Hepatol 2000;12:975-979.
106. Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987;22:1009-1024.
107. Rutgeerts P, D'Haens G, Hiele M, Geboes K, Vantrappen G. Appendectomy protects against ulcerative colitis. Gastroenterology 1994;106:1251-1253.
108. Radford-Smith GL. The role of the appendix and appendectomy in patients with IBD. IBD Monitor 2003;4:120-128.
109. Koutroubakis IE, Vlachonikolis IG, Kouroumalis EA. Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review. Inflamm Bowel Dis 2002;8:277-286.
110. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med 2001;344:808-814.
111. Frisch M, Johansen C, Mellemkjaer L, Engels EA, Gridley G, Biggar RJ, Olsen JH. Appendectomy and subsequent risk of inflammatory bowel diseases. Surgery 2001;130:36-43.
112. Fonager K, Sorensen HT, Olsen J. Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992. Intl J Epidemiol 1997;26:1003-1008.
113. Naganuma M, Iizuka B, Torii A, Ogihara T, Kawamura Y, Ichinose M, Kojima Y, Hibi T, Tokyo Gut C. Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol 2001;96:1123-1126.
114. Radford-Smith GL, Edwards JE, Purdie DM, Pandeya N, Watson M, Martin NG, Green A, Newman B, Florin TH. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002;51:808-813.
115. Cosnes J, Carbonnel F, Beaugerie L, Blain A, Reijasse D, Gendre JP. Effects of appendicectomy on the course of ulcerative colitis. Gut 2002;51:803-807.
116. Selby WS, Griffin S, Abraham N, Solomon MJ. Appendectomy protects against the development of ulcerative colitis but does not affect its course. Am J Gastroenterol 2002;97:2834-2838.
117. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology 2003;124:40-46.
118. Ramcharan S. The Walnut Creek Contraceptive Drug Study: a prospective study of the side effects of oral contraceptives. DHEW Publication No. 74-562. Washington, DC: U.S. Government Printing Office, 1981.
119. Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease-findings in the Royal College of General Practitioners Oral Contraception Study. Intl J Epidemiol 1989;18:105-107.
120. Lesko SM, Kaufman DW, Rosenberg L, Helmrich SP, Miller DR, Stolley PD, Shapiro S. Evidence for an increased risk of Crohn's disease in oral contraceptive users. Gastroenterology 1985;89:1046-1049.
121. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and Crohn's disease: a community-based matched case-control study. Gastroenterology 1989;97:1442-1447.
122. Lashner BA, Kane SV, Hanauer SB. Lack of association between oral contraceptive use and ulcerative colitis. Gastroenterology 1990;99:1032-1036.
123. Sandler RS, Wurzelmann JI, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology 1992;3:374-378.
124. Katschinski B, Fingerle D, Scherbaum B, Goebell H. Oral contraceptive use and cigarette smoking in Crohn's disease. Dig Dis Sci 1993;38:1596-1600.
125. Godet PG, May GR, Sutherland LR. Meta-analysis of the role of oral contraceptive agents in inflammatory bowel disease. Gut 1995;37:668-673.
126. Boyko EJ, Theis MK, Vaughan TL, Nicol-Blades B. Increased risk of inflammatory bowel disease associated with oral contraceptive use. Am J Epidemiol 1994;140:268-278.
127. Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Dipaolo M, Riegler G, Rigo GP, Ferrau O, Mansi C, Ingrosso M, Valpiani D. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy-a nationwide case-control study. Intl J Epidemiol 1998;27:397-404.
128. Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Gendre JP. Oral contraceptive use and the clinical course of Crohn's disease: a prospective cohort study. Gut 1999;45:218-222.
129. Wakefield AJ, Sawyerr AM, Hudson M, Dhillon AP, Pounder RE. Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991;36:1147-1150.
130. Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochen 1976;54:367-371.
131. Riordan AM, Ruxton CH, Hunter JO. A review of associations between Crohn's disease and consumption of sugars. Eur J Clin Nutr 1998;52:229-338.
132. Mayberry JF, Rhodes J, Allan R, Newcombe RG, Regan GM, Chamberlain LM, Wragg KG. Diet in Crohn's disease: two studies of current and previous habits in newly diagnosed patients. Dig Dis Sci 1981;26:444-448.
133. Tragnone A, Valpiani D, Miglio F, Elmi G, Bazzocchi G, Pipitone E, Lanfranchi GA. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol 1995;7:47-51.
134. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997;40:754-760.
135. Jarnerot G, Jammark I, Nilsson K. Consumption of refined sugar by patients with Crohn's disease, ulcerative colitis, or irritable bowel syndrome. Scand J Gastroenterol 1983;18:999-1002.
136. Russel MG, Engels LG, Muris JW, Limonard CB, Volovics A, Brummer RJ, Stockbrugger RW. "Modern life" in the epidemiology of inflammatory bowel disease: a case-control study with special emphasis on nutritional factors. Eur J Gastroenterol Hepatol 1998;10:243-249.
137. Shoda R, Matsueda K, Yamato S, Umeda N. Epidemiologic analysis of Crohn disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn disease in Japan. Am J Clin Nutr 1996;63:741-745.
138. Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000;95:1008-1013.
139. Persson PG, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology 1992;3:47-52.
140. Bergstrand O, Hellers G. Breast-feeding during infancy in patients who later develop Crohn's disease. Scand J Gastroenterol 1983;18:903-906.
141. Koletzko S, Sherman P, Corey M, Griffiths A, Smith C. Role of infant feeding practices in development of Crohn's disease in childhood. BMJ 1989;298:1617-1618.
142. Rigas A, Rigas B, Glassman M, Yen YY, Lan SJ, Petridou E, Hsieh CC, Trichopoulos D. Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhood. Ann Epidemiol 1993;3:387-392.
143. Gruber M, Marshall JR, Zielezny M, Lance P. A case-control study to examine the influence of maternal perinatal behaviors on the incidence of Crohn's disease. Gastroenterol Nurs 1996;19:53-59.
144. Thompson NP, Montgomery SM, Wadsworth ME, Pounder RE, Wakefield AJ. Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000;12:25-30.
145. Ekbom A, Adami HO, Helmick CG, Jonzon A, Zack MM. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol 1990;132:1111-1119.
146. Koletzko S, Griffiths A, Corey M, Smith C, Sherman P. Infant feeding practices and ulcerative colitis in childhood. BMJ 1991;302:1580-1581.
147. Thompson NP, Pounder RE, Wakefield AJ. Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol 1995;7:385-390.
148. Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991;100:350-358.
149. Ekbom A, Zack M, Adami HO, Helmick C. Is there clustering of inflammatory bowel disease at birth? Am J Epidemiol 1991;134:876-886.
150. Whorwell PJ, Holdstock G, Whorwell GM, Wright R. Bottle feeding, early gastroenteritis, and inflammatory bowel disease. BMJ 1979;1:382.
151. Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Scle 1994;39:555-560.
152. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-767.
153. Duggan AE, Usmani I, Neal KR, Logan RF. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998;43:494-498.
154. Montgomery SM, Pounder RE, Wakefield AJ. Infant mortality and the incidence of inflammatory bowel disease. Lancet 1997;349:472-473.
155. Wakefield AJ, Ekbom A, Dhillon AP, Pittilo RM, Pounder RE. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995;108:911-916.
156. Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994;344:508-510.
157. Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 1996;348:515-517.
158. Jones P, Fine P, Piracha S. Crohn's disease and measles. Lancet 1997;349:473.
159. Pardi DS, Tremaine WJ, Sandborn WJ, Loftus EV Jr, Poland GA, Melton U III. Perinatal exposure to measles virus is not associated with the development of inflammatory bowel disease. Inflamm Bowel Dis 1999;5:104-106.
160. Robertson DJ, Sandler RS. Measles virus and Crohn's disease: a critical appraisal of the current literature. Inflamm Bowel Dis 2001;7:51-57.
161. Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995;345:1071-1074.
162. Feeney M, Clegg A, Winwood P, Snook J. A case-control study of measles vaccination and inflammatory bowel disease. Lancet 1997;350:764-766.
163. Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol 2000;95:3507-3512.
164. Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, Black S, Shinefield H, Lewis E, Ward J, Marcy SM, Eriksen E, Destefano F, Chen R. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med 2001;155:354-359.
165. Dalziel TK. Chronic interstitial enteritis. BMJ 1913;2:1068-1070.
166. Chiodini RJ, Van Kruiningen HJ, Merkal RS, Thayer WR Jr, Coutu JA. Characteristics of an unclassified Mycobacterium species isolated from patients with Crohn's disease. J Clin Microbiol 1984;20:966-971.
167. Van Kruiningen HJ. Lack of support for a common etiology in Johne's disease of animals and Crohn's disease in humans. Inflamm Bowel Dis 1999;5:183-191.
168. Hermon-Taylor J. Protagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut 2001;49:755-756.
169. Quirke P. Antagonist. Mycobacterium avium subspecies paratuberculosis is a cause of Crohn's disease. Gut 2001;49:757-760.
170. Greenstein RJ. Is Crohn's disease caused by a mycobacterium? Comparisons with leprosy, tuberculosis, and Johne's disease. Lancet Infect Dis 2003;3:507-514.
171. Graham DY, Markesich DC, Yoshimura HH. Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology 1987;92:436-442.
172. Ryan P, Bennett MW, Aarons S, Lee G, Collins JK, O'Sullivan GC, O'Connell J, Shanahan F. PCR detection of Mycobacterium paratuberculosis in Crohn's disease granulomas isolated by laser capture microdissection. Gut 2002;51:665-670.
173. Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G, Pickup R, Hermon-Taylor J. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol 2003;41:2915-2923.
174. Gui GP, Thomas PR, Tizard ML, Lake J, Sanderson JD, Hermon-Taylor J. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolide antibiotics. J Antimicrob Chemother 1997;39:393-400.
175. Shafran I, Kugler L, El-Zaatari FA, Naser SA, Sandoval J. Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease. Dig Liver Dis 2002;34:22-28.
176. Borody TJ, Leis S, Warren EF, Surace R. Treatment of severe Crohn's disease using antimycobacterial triple therapy-approaching a cure? Dig Liver Dis 2002;34:29-38.
177. Borgaonkar M, MacIntosh D, Fardy J, Simms L. Anti-tuberculous therapy for maintenance of remission in Crohn's disease (Cochrane Review). The Cochrane Library. Vol. Issue 2. Oxford: Update Software; 2003.
178. Borgaonkar MR, MacIntosh DG, Fardy JM. A meta-analysis of antimycobacterial therapy for Crohn's disease. (comment) Am J Gastroenterol 2000;95:725729.